Tuesday, October 23, 2012 Monday, October 22, 2012 Friday, October 19, 2012 Thursday, October 18, 2012- Stryker Reiterated at Buy and 3 Must-See Reiterated Ratingsat Wall St. Cheat Sheet (Thu, Oct 18)
- SodaStream Fundamentals Remain Strong and 3 Stock Analyses to Eyeat Wall St. Cheat Sheet (Thu, Oct 18)
- Processing Aegerion Pharmaceuticals' Recent Rallyat Seeking Alpha (Thu, Oct 18)
- 3 FDA Approval Recommendationsat Motley Fool (Thu, Oct 18)
- Aegerion Drug Wins Panel Support for Cholesterol Diseaseat Bloomberg (Thu, Oct 18)
- FDA Panel Recommends Approval Of Mipomersen For Familial Hypercholesterolemiaat Forbes (Thu, Oct 18)
- Movers roundup: Vivus, Align TechnologyAP (Thu, Oct 18)
- Aegerion hits annual high on FDA panel voteAP (Thu, Oct 18)
- Today's Health Care Pops and Plungesat Motley Fool (Thu, Oct 18)
- Isis Pharma/Genzyme FDA Panel Live Blogat TheStreet (Thu, Oct 18)
- Top 5 Stocks With Insider Sells Filed On October 17 To Considerat Seeking Alpha (Thu, Oct 18)
- Aegerion price target raised to $30 from $19 at Deutsche Banktheflyonthewall.com (Thu, Oct 18)
Wednesday, October 17, 2012Add AEGR News to My Yahoo!  | |
|